BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2020 9:45:46 AM | Browse: 1077 | Download: 2107
 |
Received |
|
2020-05-26 09:16 |
|
Peer-Review Started |
|
2020-05-26 09:17 |
|
First Decision by Editorial Office Director |
|
2020-06-13 04:55 |
|
Return for Revision |
|
2020-06-13 04:55 |
|
Revised |
|
2020-06-24 03:19 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-07-22 10:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-07-23 01:54 |
|
Articles in Press |
|
2020-07-23 01:54 |
|
Edit the Manuscript by Language Editor |
|
2020-07-27 19:16 |
|
Typeset the Manuscript |
|
2020-08-03 14:54 |
|
Publish the Manuscript Online |
|
2020-08-25 09:45 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zheng Guo, Jing Wang, Li Li, Rong Liu, Jin Fang and Bin Tie |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bin Tie, MAMS, Attending Doctor, Interventional Medicine, The First Hospital of Lanzhou University, No. 1, Donggang West Road, Lanzhou 730000, Gansu Province, China. tie12bin@163.com |
| Key Words |
miR-1271; Glypican-3; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Teal-time quantitative polymerase chain reaction; Tumor recurrence |
| Core Tip |
The results of this study prove that the serum GPC3 level in patients with hepatocellular carcinoma recurrence after transcatheter arterial chemoembolization is significantly higherthan Remission group, and miR-1271 is significantly lower. The combined detection of serum GPC3 and miR-1271 has an important clinical reference value for evaluating the prognosis of hepatocellular carcinoma, Serum GPC3 and miR-1271 levels can help determine tumor recurrence, prognosis evaluation. |
| Publish Date |
2020-08-25 09:45 |
| Citation |
Guo Z, Wang J, Li L, Liu R, Fang J, Tie B. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Clin Cases 2020; 8(16): 3493-3502
|
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i16/3493.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i16.3493 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
